Notes and references
1 Reviews on FMS: (a) W. Zhang, Arkivo, 2004, (i), 101–109;
(b) Q. S. Zhang and D. P. Curran, Chem.–Eur. J., 2005, 11,
4866–4880; (c) W. Zhang, in Fluorine in Medicinal Chemistry and
Chemical Biology, ed. I. Ojima, Wiley-Blackwell, 2009, pp. 335–359.
2 (a) Z. Y. Luo, Q. S. Zhang, Y. Oderaotoshi and D. P. Curran,
Science, 2001, 291, 1766–1769; (b) W. Zhang, Z. Luo,
C. H.-T. Chen and D. P. Curran, J. Am. Chem. Soc., 2002, 124,
10443–10450; (c) D. P. Curran and T. Furukawa, Org. Lett., 2002,
4, 2233–2235; (d) S. Manku and D. P. Curran, J. Comb. Chem.,
2005, 7, 63–68.
3 (a) Q. S. Zhang, H. J. Lu, C. Richard and D. P. Curran, J. Am. Chem.
Soc., 2004, 126, 36–37; (b) S. Dandapani, M. Jeske and D. P. Curran,
Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 12008–12012;
(c) C. S. Wilcox, V. Gudipati, L. Lu, S. Turkyilmaz and
D. P. Curran, Angew. Chem., Int. Ed., 2005, 44, 6938–6940;
(d) V. Gudipati, D. P. Curran and C. S. Wilcox, J. Org. Chem.,
Fig. 2 TLC of crude compounds 11 and 13. Left, on normal silica gel
developed with 2 : 1 hexanes-EtOAc; right, on fluorous silica gel
developed with 4 : 1 MeOH–H2O. aCrude sample containing unreacted
compound 9.
2006, 71, 3599–3607; (e) Y. Fukui, A. M. Bruckner, Y. Shin,
¨
R. Balachandran, B. W. Day and D. P. Curran, Org. Lett., 2006, 8,
301–304; (f) D. P. Curran, G. Moura-Lett and M. Pohlman, Angew.
Chem., Int. Ed., 2006, 45, 2423–2426; (g) F. Yang and D. P. Curran,
J. Am. Chem. Soc., 2006, 128, 14200–14205; (h) D. P. Curran and
B. Sui, J. Am. Chem. Soc., 2009, 131, 5411–5413; (i) R. Jogireddy,
P.-Y. Dakas, G. Valot, S. Barlueng and N. Winssinger, Chem.–Eur.
J., 2009, 15, 11498–11506; (j) K. Zhang and D. P. Curran, Synlett,
2010, 667–671.
4 Q. S. Zhang, A. Rivkin and D. P. Curran, J. Am. Chem. Soc., 2002,
124, 5774–5781.
5 (a) W. Zhang, Y. Lu, C. H.-T. Chen, L. Zeng and D. B. Kassel,
J. Comb. Chem., 2006, 8, 687–695; (b) S. Manku and D. P. Curran,
J. Org. Chem., 2005, 70, 4470–4473.
diastereomers detected by LC-MS but unable to be isolated
due to the very small amount could be 1b0 and 1c0 which are
the epimers of 1b and 1c, respectively.
To confirm the epimerization could happen at the
hydantoin formation step, a major 1,3-dipolar cycloaddition
product 11a isolated from the reaction mixture was used for
urea formation and subsequent cyclization reactions. A single
urea compound 12a was formed, but two hydantoin-fused
compounds 1a and 1a0 were detected in a ratio of 2 : 1.
6 (a) M. Tojino and M. Mizuno, Tetrahedron Lett., 2008, 49,
5920–5923; (b) M. Kojima, Y. Nakamura, S. Ito and
S. Takeuchi, Tetrahedron Lett., 2009, 59, 6143–6149.
To show the advantage of FDMS,
a non-fluorous
diastereomeric mixture 13 prepared by the reaction of 9 and
L-alanine methyl ester was tested side-by-side with fluorous
diastereomeric mixture 11 on normal and fluorous TLC plates,
respectively (Fig. 2). On the normal silica gel, crude reaction
mixtures 11 and 13 both gave tailed spots because the
diastereomers in each mixture have slightly different polarities.
Compounds 11 and 13 could not be separated from unreacted
compound 9. However, on the fluorous TLC, crude sample 11
gave a spot at the baseline and it was well-separated from 9.
Because it is a fluorous tag-based separation, diastereomers
bearing the same tag should have the same retention on
fluorous TLC. On the other hand, crude sample 13 had almost
no retention on fluorous TLC and gave a mixture spot close
to the solvent front. This TLC experiment explains why
fluorous-tagged diastereomeric mixture 11 can be collected
as a single fraction and separated from non-fluorous component
9 by F-SPE.
7 H. Jia and J. M. Tour, J. Org. Chem., 2005, 70, 3396–3424.
8 Z.-X. Jiang and Y. B. Yu, J. Org. Chem., 2010, 75, 2044–2049.
9 (a) T. Tonoi and K. Mikami, Eur. J. Org. Chem., 2007, 1730–1733;
(b) T. Tonoi, W. Zhang, D. P. Curran and K. Mikami, Chirality,
2008, 20, 597–603; (c) T. Yajima, T. Tonoi, H. Nagano, Y. Tomita
and K. Mikami, Eur. J. Org. Chem., 2010, 2461–2464.
10 (a) M. D. Burke, E. M. Berger and S. L. Schreiber, Science, 2003,
302, 613–618; (b) D. R. Spring, Org. Biomol. Chem., 2003, 1,
3867–3870; (c) P. Arya, R. Joseph, Z. Gan and B. Rakic, Chem.
Biol., 2005, 12, 163–180; (d) D. Tan, Nat. Chem. Biol., 2005, 1,
74–84.
11 W. Zhang and D. P. Curran, Tetrahedron, 2006, 62, 11837–11865.
12 M. L. Bolognesi, M. Bartolini, A. Cavalli, V. Andrisano,
M. Rosini, A. Minarin and C. Melchiorre, J. Med. Chem., 2004,
47, 5945–5952.
13 J. Olsen, P. Seiler, B. Wagner, H. Fisher, T. Tschopp U.
Obst-Sander, D. W. Banner, M. Kansy, K. Muller and
F. Diederrich, Org. Biomol. Chem., 2004, 2, 1339–1352.
14 (a) Y.-D. Gong, S. Najdi, M. M. Olmstead and M. J. Kurth,
J. Org. Chem., 1998, 63, 3081–3086; (b) Y.-D. Gong, H.-Y. Sohn
and M. J. Kurth, J. Org. Chem., 1998, 63, 4854–4856;
(c) Y.-D. Gong, Y.-D. Kim, S.-E. Yoo and M. J. Kurth, Bull.
Chem. Soc. Jpn., 2002, 75, 2477–2480.
In summary, FDMS is developed as a new solution-phase
method for the synthesis of diastereomeric products. The
mixture of fluorous-tagged diastereomeric intermediates could
be easily isolated by F-SPE without separation from each
other, which overcomes the major separation issue and
increases the efficiency of mixture synthesis of diastereomers.
In this project, eight possible diastereomers of hydantoin-fused
hexahydrochromeno[4,3-b]pyrroles were synthesized by FDMS
and six of them were isolated for structure characterizations.
Use of FDMS to prepare compound libraries with substitution,
skeleton, and stereochemistry diversities is in progress and will
be reported in due course.
15 (a) D. A. Barr, R. Grigg, H. Q. N. Gunaratne, J. Kemp,
P. McMeekin and V. Sridharan, Tetrahedron, 1988, 44,
4727–4730; (b) R. Stohler, F. Wah and A. Pfaltz, Synthesis,
2005, 1431–1436.
16 I. Coldham and R. Hufton, Chem. Rev., 2005, 105, 2765–2809.
17 (a) P. N. Confalone and E. M. Huie, J. Am. Chem. Soc., 1984, 106,
7175–7178; (b) A. F. Khlebnikov, M. S. Novikov, R. R. Kostikov
and J. Kopf, Russ. J. Org. Chem., 2005, 41, 1341–1348;
(c) J. Pospisil and M. Potacek, Tetrahedron, 2007, 63, 337–346.
18 (a) Fluorous media available from Fluorous Technologies, Inc;
(b) WZ and DPC hold an equity interest in this company.
19 Crystal data for compound 1a: C24H23BrN2O6, M = 515.35,
monoclinic, a = 13.396(2), b = 6.8114(12), c = 24.048(4) A,
b = 90.825(4)1, V = 2194.1(7) A3, T = 173 K, space group P21/c
This work was supported by the National Institutes
of General Medical Sciences P41GM081269 (WZ) and
P50GM067082 (DPC).
(no. 14), Z = 4, 26 044 reflections measured, 7225 unique (Rint
=
0.054) which were used in all calculations. The final wR(F2) was
0.1345 (using all data).
c
7580 Chem. Commun., 2010, 46, 7578–7580
This journal is The Royal Society of Chemistry 2010